Novel Form of Curcumin Improves Endothelial Function in Young, Healthy Individuals: A Double-Blind Placebo Controlled Study
Curcumin, a turmeric extract, may protect against cardiovascular diseases by enhancing endothelial function. In this randomized controlled double-blind parallel prospective study, fifty-nine healthy adults were assigned to placebo, 50 mg (50 mg), or 200 mg (200 mg) curcumin, for 8 weeks. The higher...
Saved in:
Main Authors: | Jonathan M. Oliver, Lee Stoner, David S. Rowlands, Aaron R. Caldwell, Elizabeth Sanders, Andreas Kreutzer, Joel B. Mitchell, Martin Purpura, Ralf Jäger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Nutrition and Metabolism |
Online Access: | http://dx.doi.org/10.1155/2016/1089653 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study
by: Barbara Grube, et al.
Published: (2015-01-01) -
The Effect of Synbiotic Supplementation on Self-Reported Aggression in Healthy Adult Men: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Rahele Sadat Montazeri, et al.
Published: (2025-02-01) -
Efficacy and safety of ashwagandha root extract on sexual health in healthy women: findings of a prospective, randomized, double-blind, placebo-controlled study
by: Amit Shrenikraj Mutha, et al.
Published: (2025-12-01) -
Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia)
by: Tawasapon Thambamroong, et al.
Published: (2022-01-01) -
Experimental hypothermia by cold air: a randomized, double-blind, placebo-controlled crossover trial
by: Ane M. Helland, et al.
Published: (2025-01-01)